Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 1/2015

Open Access 01-12-2016 | Research article

Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus

Authors: Ozra Tabatabaei-Malazy, Amir Ramezani, Rasha Atlasi, Bagher Larijani, Mohammad Abdollahi

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2015

Login to get access

Abstract

Background

Scientometric analysis is increasingly used for research assessment. We aimed to perform a scientometric analysis of research productivity in field of antioxidative hypoglycemic herbal medicine and diabetes.

Methods

Some of search terms were “type 2 diabetes”, “antioxidant”, “herb”, “phytotherapy”, “ethnopharmacology”, “Chinese medicine”, “traditional medicine”, in Scopus web databases until January 2015, and limited to human. The collected data were used to generate the specific features such as publication year, main journal in the field, citation, subject area, and co-authorship network of authors and institutes. Data was analyzed using analysis tools provided by Scopus database, SPSS version 11 and VOSviewer software.

Results

Overall, 468 studies were related to this topic in human. The number of publications in the field showed an increasing trend. Majority of the published papers were original articles (71 %) and the most productive year was 2013. Top subject areas were medicine followed by drug. The first productive country was the US. The documents were cited totally 10724 times with average citation/article 22.91, and h-index 55. The highest cited article was a systematic review study, and top source was “Journal of Ethnopharmacology”. The highest international collaboration was with the US. Top authors and institutes in the co-authorship network assessment were from Iran.

Conclusions

A promising scientific productivity is shown in the studied field world wide. This study provided practical information to researchers who look for studies with potentially highly citation, and also would be helpful for researchers to conduct better researches that eventually could lead to more publications in this field.
Literature
4.
go back to reference Hasani-Ranjbar S, Larijani B. Medicinal plants as potential new target drugs in endocrine disorders-review article. Iran J Public Health. 2014;43:24–34. Hasani-Ranjbar S, Larijani B. Medicinal plants as potential new target drugs in endocrine disorders-review article. Iran J Public Health. 2014;43:24–34.
5.
go back to reference Dabaghian FH, Kamalinejad M, Shojaei A, Fard MA. Presenting anti-diabetic plants in Iranian traditional medicine. J Diabetes and Endocrinol. 2012;3:61–7.CrossRef Dabaghian FH, Kamalinejad M, Shojaei A, Fard MA. Presenting anti-diabetic plants in Iranian traditional medicine. J Diabetes and Endocrinol. 2012;3:61–7.CrossRef
6.
go back to reference Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arc Med Sci. 2008;4:285–92. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arc Med Sci. 2008;4:285–92.
8.
go back to reference Bosman J, Mourik IV, Rasch M, Sieverts E, Verhoeff H. Scopus reviewed and compared: The coverage and functionality of the citation database Scopus, including comparisons with Web of Science and Google Scholar. Utrecht University Repository. 2006. Bosman J, Mourik IV, Rasch M, Sieverts E, Verhoeff H. Scopus reviewed and compared: The coverage and functionality of the citation database Scopus, including comparisons with Web of Science and Google Scholar. Utrecht University Repository. 2006.
9.
go back to reference Bar-Ilan J. Citations to the “Introduction to informetrics” indexed by WOS, Scopus and Google Scholar. Scientometrics. 2010;82:495–506.CrossRef Bar-Ilan J. Citations to the “Introduction to informetrics” indexed by WOS, Scopus and Google Scholar. Scientometrics. 2010;82:495–506.CrossRef
16.
go back to reference Schreiber M. How relevant is the predictive power of the h-index? A case study of the time-dependent Hirsch index. J Informetics. 2013;7:325–9.CrossRef Schreiber M. How relevant is the predictive power of the h-index? A case study of the time-dependent Hirsch index. J Informetics. 2013;7:325–9.CrossRef
17.
go back to reference Aghaei Chadegani A, Salehi H, MdYunus M, Farhadi H, Fooladi M, Farhadi M, Ale EN. A comparison between two main academic literature collections: Web of science and Scopus databases. Asian Soc Sci. 2013;9:18–26. Aghaei Chadegani A, Salehi H, MdYunus M, Farhadi H, Fooladi M, Farhadi M, Ale EN. A comparison between two main academic literature collections: Web of science and Scopus databases. Asian Soc Sci. 2013;9:18–26.
22.
go back to reference Tabatabaei-Malazy O, Larijani B, Abdollahi M. A novel management of diabetes by means of strong antioxidants’ combination. J Med Hypotheses Ideas. 2013;7:25–30.CrossRef Tabatabaei-Malazy O, Larijani B, Abdollahi M. A novel management of diabetes by means of strong antioxidants’ combination. J Med Hypotheses Ideas. 2013;7:25–30.CrossRef
24.
go back to reference Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. Oxford Centre for Evidence-Based Medicine; Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document) Available in: www.cebm.net/index.aspx?o=5653. Accessed 11 Aug 2016. Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. Oxford Centre for Evidence-Based Medicine; Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document) Available in: www.​cebm.​net/​index.​aspx?​o=​5653. Accessed 11 Aug 2016.
25.
go back to reference Larijani B, Majdzadeh R, Delavari A, Rajabi F, Khatibzadeh S, Esmailzadeh H, et al. Iran’s health innovation and science development plan by 2025. Iran J Public Health. 2009;38 Suppl 1:13–6. Larijani B, Majdzadeh R, Delavari A, Rajabi F, Khatibzadeh S, Esmailzadeh H, et al. Iran’s health innovation and science development plan by 2025. Iran J Public Health. 2009;38 Suppl 1:13–6.
27.
go back to reference Giuliani F, De Petris MP, Nico G. Assessing scientific collaboration through co-authorship and content sharing. Scientometrics. 2010;85:13–28.CrossRef Giuliani F, De Petris MP, Nico G. Assessing scientific collaboration through co-authorship and content sharing. Scientometrics. 2010;85:13–28.CrossRef
30.
go back to reference Keshtkar A, Djalalinia SH, Khashayar P, Peykari N, Mohammadi Z, Larijani B. Iranian Health Research Networks and vision of Iran by 2025: a case of Virtual Health Network in EMRI. Iran J Public Health. 2013;42:78–83.PubMedPubMedCentral Keshtkar A, Djalalinia SH, Khashayar P, Peykari N, Mohammadi Z, Larijani B. Iranian Health Research Networks and vision of Iran by 2025: a case of Virtual Health Network in EMRI. Iran J Public Health. 2013;42:78–83.PubMedPubMedCentral
Metadata
Title
Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus
Authors
Ozra Tabatabaei-Malazy
Amir Ramezani
Rasha Atlasi
Bagher Larijani
Mohammad Abdollahi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2015
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/s40200-016-0273-3

Other articles of this Issue 1/2015

Journal of Diabetes & Metabolic Disorders 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.